[go: up one dir, main page]

Ayyar, 2011 - Google Patents

Generation and optimisation of novel recombinant antibodies for improved cardiac diagnostics

Ayyar, 2011

View PDF
Document ID
11412571036542675095
Author
Ayyar V
Publication year

External Links

Snippet

I am indebted to my family (my late father, my family, my younger brother, and my grandmother) for their unfaltering love and support. I am especially indebted to my late father, who worked industriously to support my education, but who never lived long enough …
Continue reading at doras.dcu.ie (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency

Similar Documents

Publication Publication Date Title
Pini et al. Phage display of antibody fragments
Turner et al. Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology
CN1711476B (en) Noncompetitive immunoassays for small analytes
JP2024001208A (en) Adrenomedullin (adm) for diagnosis and/or prediction of dementia, and anti-adrenomedullin binder for use in treatment or prevention of dementia
KR102795552B1 (en) Antibody specifically binding to tryptophanyl-tRNA synthetase protein and uses thereof
EP0934953A2 (en) Complex specific antibodies, method of preparation and uses thereof
Deramchia et al. In vivo phage display to identify new human antibody fragments homing to atherosclerotic endothelial and subendothelial tissues
CA3046850A1 (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in intervention and therapy of congestion in a patient in need thereof
JP2001264329A (en) Examination for measuring type ii collagen in urine
Kiguchi et al. Antibodies and engineered antibody fragments against M13 filamentous phage to facilitate phage-display-based molecular breeding
JPWO2004016782A1 (en) Methods for measuring interactions between multiple proteins
Eteshola Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display
Putelli et al. A fibrin-specific monoclonal antibody from a designed phage display library inhibits clot formation and localizes to tumors in vivo
US9782501B2 (en) Antibodies for molecular imaging of vulnerable plaques in atherosclerosis
JP4566911B2 (en) Cobalamin analysis method
Ayyar Generation and optimisation of novel recombinant antibodies for improved cardiac diagnostics
Neri et al. Antibodies from phage display libraries as immunochemical reagents
Schlattner et al. Isoenzyme-directed selection and characterization of anti-creatine kinase single chain Fv antibodies from a human phage display library
RU2763178C2 (en) Antibodies for laboratory diagnostics of the concentration of interleukin-11
Watkins et al. Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion
JP7190674B2 (en) Antibody and complex that bind to norovirus, detection device and detection method using the same
Kumano-Kuramochi et al. Screening, expression, and characterization of an anti-human oxidized low-density lipoprotein single-chain variable fragment
McDonnell Development of novel antibody-based diagnostics for the early and rapid detection of cardiac markers
JP2001515921A (en) Monoclonal antibodies that bind testosterone
JP7450179B2 (en) Kawasaki disease prevalence determination kit and Kawasaki disease prevalence determination method